Your browser doesn't support javascript.
loading
Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients.
Hennequin, Audrey; Derangère, Valentin; Boidot, Romain; Apetoh, Lionel; Vincent, Julie; Orry, David; Fraisse, Jean; Causeret, Sylvain; Martin, François; Arnould, Laurent; Beltjens, Françoise; Ghiringhelli, François; Ladoire, Sylvain.
Affiliation
  • Hennequin A; Department of Medical Oncology Center Georges François Leclerc; Dijon, France; Faculté des Sciences de Santé; Université de Bourgogne; Dijon, France.
  • Derangère V; Faculté des Sciences de Santé; Université de Bourgogne; Dijon, France; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 866; Dijon, France; Department of Biology and Pathology of Tumors. Plateform of Genetic; Immunology and Histology of Solid Tumors; Centre Georges-François Lec
  • Boidot R; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 866; Dijon, France; Department of Biology and Pathology of Tumors. Plateform of Genetic; Immunology and Histology of Solid Tumors; Centre Georges-François Leclerc; Dijon, France.
  • Apetoh L; Department of Medical Oncology Center Georges François Leclerc; Dijon, France; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 866; Dijon, France; Department of Biology and Pathology of Tumors. Plateform of Genetic; Immunology and Histology of Solid Tumors; Centre Georges-Fran
  • Vincent J; Department of Medical Oncology Center Georges François Leclerc ; Dijon, France.
  • Orry D; Department of Surgical Oncology. Center Georges François Leclerc ; Dijon, France.
  • Fraisse J; Department of Surgical Oncology. Center Georges François Leclerc ; Dijon, France.
  • Causeret S; Department of Surgical Oncology. Center Georges François Leclerc ; Dijon, France.
  • Martin F; Faculté des Sciences de Santé; Université de Bourgogne; Dijon, France; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 866; Dijon, France.
  • Arnould L; Department of Biology and Pathology of Tumors. Plateform of Genetic; Immunology and Histology of Solid Tumors; Centre Georges-François Leclerc ; Dijon, France.
  • Beltjens F; Department of Biology and Pathology of Tumors. Plateform of Genetic; Immunology and Histology of Solid Tumors; Centre Georges-François Leclerc ; Dijon, France.
  • Ghiringhelli F; Department of Medical Oncology Center Georges François Leclerc; Dijon, France; Faculté des Sciences de Santé; Université de Bourgogne; Dijon, France; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 866; Dijon, France; Department of Biology and Pathology of Tumors. Plateform of
  • Ladoire S; Department of Medical Oncology Center Georges François Leclerc; Dijon, France; Faculté des Sciences de Santé; Université de Bourgogne; Dijon, France; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 866; Dijon, France; Department of Biology and Pathology of Tumors. Plateform of
Oncoimmunology ; 5(2): e1054598, 2016 Feb.
Article in En | MEDLINE | ID: mdl-27057426

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Oncoimmunology Year: 2016 Document type: Article Affiliation country: France Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Oncoimmunology Year: 2016 Document type: Article Affiliation country: France Country of publication: United States